Whitney Robinson
Whitney Robinson counsels clients on corporate and securities issues including mergers and acquisitions, capital markets transactions, and securities regulations matters and filings.
Whitney earned her law degree from the University of Memphis Cecil C. Humphreys School of Law and a B.S. in business administration from the University of Tennessee.
Memberships
American Health Law Association (AHLA)
Representative Experience
-
Read More
Representation of Triple Tree Capital Partners and Vestar Capital Partners in the merger of their respective portfolio companies, The Emily Program and Veritas Collaborative.
-
Read More
Representation of Louisiana-Pacific Corporation in its offering of $350,000,000 of 3.625% senior notes due 2029.
-
Read More
Representation of Regent Surgical Health, an ambulatory surgery center management and development company, in its strategic investment from TowerBrook Capital Partners L.P., an international investment management firm, and Ascension Capital, an investment affiliate of Ascension.
-
Read More
Representation of ClearPoint Neuro, Inc. in its public offering of 2,127,660 shares with proceeds of $46,800,000.
-
Read More
Representation of ClearPoint Neuro, Inc. in its public offering of 2,127,660 shares with proceeds of $46,800,000. B. Riley Securities acted as book-running manager and Lake Street Capital Markets, LLC acted as co-manager for the offering.
-
Read More
Representation of Premise Health, the largest direct health care provider in the country and OMERS portfolio company, in its acquisition of Sonic Boom Wellness, a provider of corporate wellness technology
-
Read More
-
Read More
We represented ClearPoint Neuro, Inc. (f/k/a MRI Interventions, Inc.), a global therapy-enabling platform company providing navigation and delivery to the brain, in its $17.5 million strategic investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management, with $10.0 million of notes funded by PTC and $7.5 million of notes funded by Petrichor. With the net proceeds from the sale of the notes to PTC and Petrichor, the ClearPoint Neuro intends to repay in full its existing secured indebtedness, and to fund product commercialization, internal research and development, and general corporate requirements. Additionally, we advised ClearPoint Neuro in the draw of $7.5 million additional proceeds from Petrichor in December 2020. ClearPoint Neuro intends to use net proceeds to continue funding global product commercialization, external strategic portfolio partnerships, and internal research and development efforts.
-
Read More
Representation of OptionOne, a specialty pharmacy providing home and alternate-site infusion therapies through a comprehensive clinical approach to patient care, in its sale to Amerita, Inc., a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. Terms of the transaction were not disclosed.
-
Read More
Representation of Triage Consulting Group, a healthcare revenue integrity company in its acquisition by Revint Solutions, a leader in technology-enabled revenue integrity solutions for healthcare providers
Media Mentions & Firm News
Additional News & Insights
Publication:
- “Hazed and Confused: Overcoming Roadblocks to Liability by Clarifying a Duty of Care Through a Special Relationship Between a National Greek Life Organization and Local Chapter Members,” 49 U. Mem. L. Rev. 485 (2019)
Accolades
The University of Memphis Law Review — Editor-in-Chief, Volume 49; Staff Member, Volume 48
University of Memphis Cecil C. Humphreys School of Law Writing Center — Writing Fellow
Dean’s Distinguished Service Award
Dean’s Award for Excellence — Best Memorandum, Best Brief, and Best Oral Advocate
CALI Excellence for the Future Award — Property I
The University of Memphis Law Review — Best Note Award (2019)